Munich - Delayed Quote EUR

PT Kalbe Farma Tbk (LCLA.MU)

Compare
0.0930 +0.0010 (+1.09%)
As of 5:25 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
31,598,456,389.5920
30,449,134,077.6180
28,933,502,646.7190
26,261,194,512.3130
23,112,654,991.2240
--
Cost of Revenue
19,483,733,327.7810
18,625,888,544.2340
17,230,235,543.1710
14,977,410,271.0490
12,866,332,497.4520
--
Gross Profit
12,114,723,061.8110
11,823,245,533.3840
11,703,267,103.5480
11,283,784,241.2640
10,246,322,493.7710
--
Operating Expense
8,173,876,524.9550
8,198,108,504.3600
7,478,612,740.8750
7,279,598,645.8370
6,695,978,589.4610
--
Operating Income
3,940,846,536.8560
3,625,137,029.0240
4,224,654,362.6730
4,004,185,595.4270
3,550,343,904.3100
--
Net Non Operating Interest Income Expense
40,352,110.8990
-6,886,246.3790
26,768,042.3240
53,407,759.2960
61,978,867.1940
--
Pretax Income
4,034,257,209.2930
3,606,237,203.8100
4,458,896,905.3500
4,143,264,634.7740
3,627,632,574.7440
--
Tax Provision
941,707,429.0250
827,832,384.3090
1,008,813,493.0590
911,256,951.4930
828,010,058.9300
--
Net Income Common Stockholders
3,042,846,738.1110
2,766,748,040.0550
3,382,209,769.0150
3,183,621,310.0430
2,733,259,864.5960
--
Diluted NI Available to Com Stockholders
3,042,846,738.1110
2,766,748,040.0550
3,382,209,769.0150
3,183,621,310.0430
2,733,259,864.5960
--
Basic EPS
65.87
59.81
72.71
67.92
58.31
--
Diluted EPS
65.87
59.81
72.71
67.92
58.31
--
Basic Average Shares
46,181,286.5920
46,255,641.4100
46,515,940.5260
46,872,947.1100
46,873,434.4390
--
Diluted Average Shares
46,243,209.3100
46,255,641.4100
46,515,940.5260
46,872,947.1100
46,873,434.4390
--
Rent Expense Supplemental
105,044,096.8440
98,288,702.7690
96,661,221.1610
100,799,402.2340
97,714,748.2710
--
Total Expenses
27,657,609,852.7360
26,823,997,048.5940
24,708,848,284.0460
22,257,008,916.8860
19,562,311,086.9130
--
Net Income from Continuing & Discontinued Operation
3,042,846,738.1110
2,766,748,040.0550
3,382,209,769.0150
3,183,621,310.0430
2,733,259,864.5960
--
Normalized Income
3,038,501,079.0851
2,753,694,582.7354
3,370,492,781.2103
3,163,633,340.9718
2,859,104,168.0502
--
Interest Income
123,153,100.0770
88,217,597.4670
81,827,367.7380
110,792,114.4450
151,559,182.0390
--
Interest Expense
70,859,050.2600
82,958,206.7530
41,225,899.5960
45,485,899.8930
75,836,781.2680
--
Net Interest Income
40,352,110.8990
-6,886,246.3790
26,768,042.3240
53,407,759.2960
61,978,867.1940
--
EBIT
4,105,116,259.5530
3,689,195,410.5630
4,500,122,804.9460
4,188,750,534.6670
3,703,469,356.0120
--
EBITDA
4,443,857,073.8200
4,022,845,625.1170
4,833,897,508.1520
4,536,831,893.6430
4,042,348,280.0300
--
Reconciled Cost of Revenue
19,483,733,327.7810
18,625,888,544.2340
17,230,235,543.1710
14,977,410,271.0490
12,866,332,497.4520
--
Reconciled Depreciation
338,740,814.2670
333,650,214.5540
333,774,703.2060
348,081,358.9760
338,878,924.0180
--
Net Income from Continuing Operation Net Minority Interest
3,042,846,738.1110
2,766,748,040.0550
3,382,209,769.0150
3,183,621,310.0430
2,733,259,864.5960
--
Total Unusual Items Excluding Goodwill
5,668,948.7640
16,942,766.2570
15,143,065.9550
25,623,529.8580
-36,009,599.8830
--
Total Unusual Items
5,668,948.7640
16,942,766.2570
15,143,065.9550
25,623,529.8580
62,044,323.8840
--
Normalized EBITDA
4,438,188,125.0560
4,005,902,858.8600
4,818,754,442.1970
4,511,208,363.7850
3,980,303,956.1460
--
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
--
Tax Effect of Unusual Items
1,323,289.7381
3,889,308.9374
3,426,078.1503
5,635,560.7868
-8,219,220.1958
--
12/31/2019 - 12/23/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade